drugset / Trial / NCT00994383

Comparative Bioavailability Study of Morphine Sulfate Immediate Release and Controlled Release

NCT00994383

Completed 36 enrolled Roxane Laboratories
RandomizedCrossoverOpen-labelTreatment

Summary

Characterize the steady-state pharmacokinetics of morphine after oral administration of Roxane Laboratories' morphine sulfate immediate release tablets and oral solution and to compare their pharmacokinetics to that of AVINZA.

Timeline

Start
2007-01
Primary completion
2007-01
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified 15 mg Oral
Subject Morphine Other / unclassified 30 mg Oral
Subject Morphine Other / unclassified 120 mg Oral

Indications

No indication recorded.